{
    "title": "Danish drugmaker Novo Nordisk nudges up forecasts after Q1 result",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4468978/Drugmaker-Novo-Nordisk-nudges-year-profit-outlook-Q1-beat.html",
    "date": "2017-05-03",
    "keywords": [
        "percent",
        "market",
        "range",
        "jorgensen",
        "operating",
        "profit",
        "quarter",
        "drug",
        "forecast",
        "competition",
        "pressure",
        "novo",
        "obesity",
        "care",
        "firstquarter",
        "share",
        "price",
        "company",
        "year",
        "bid",
        "victoza",
        "insulin",
        "copenhagen",
        "maker",
        "wednesday",
        "firm",
        "target",
        "president",
        "nordisk",
        "high",
        "gmt",
        "allinall",
        "sentiment",
        "relief",
        "guidance",
        "nudge",
        "consensus",
        "fy",
        "deutsche",
        "bank",
        "research",
        "note",
        "growth",
        "end",
        "change",
        "environment",
        "hence",
        "risk",
        "executive",
        "poll",
        "cost",
        "control",
        "ceo",
        "jan",
        "september",
        "firstever",
        "pharmacy",
        "benefit",
        "health",
        "pricing",
        "diabetes",
        "glp1",
        "imitation",
        "hormone",
        "production",
        "absorption",
        "point",
        "time",
        "indication",
        "level",
        "tune",
        "reason",
        "fenton",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}